Hjem › Blærekreft › South Carolina › Myrtle Beach
Kliniske studier for Blærekreft i Myrtle Beach, SC
10 studier for Blærekreft søker deltakere på steder i og rundt Myrtle Beach (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- MUSC Hematology-Oncology at Murrells Inlet, Murrells Inlet · 13 mi unna
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
RekruttererFase 1
- Grand Strand Medical Center, Myrtle Beach
- AUC Urologists, LLC, Myrtle Beach
- Carolina Urologic Research Center, LLC, Myrtle Beach
- og 2 flere
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RekruttererObservasjonsstudie
- Carolina Urologic Research Center, Myrtle Beach
A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
RekruttererFase 1/2
- Carolina Urologic Research Center ( Site 0006), Myrtle Beach
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
RekruttererFase 2
- Carolina Urologic Research Center, LLC, Myrtle Beach
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
RekruttererFase 2
- Carolina Urologic Research Center, Myrtle Beach
Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
RekruttererFase 3
- START - Carolinas, Myrtle Beach
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
RekruttererFase 1
- Carolina Urologic Research Center, Myrtle Beach
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
RekruttererFase 1/2
- Carolina Urologic Research Center, LLC, Myrtle Beach
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
RekruttererFase 3
- Research Site, Myrtle Beach
Blærekreft-studier i andre byer
- New York City, NY35 studier
- Nashville, TN31 studier
- Houston, TX31 studier
- Dallas, TX27 studier
- Washington, DC26 studier
- Boston, MA26 studier
- Baltimore, MD24 studier
- Los Angeles, CA24 studier
- St. Louis, MO22 studier
- Seattle, WA21 studier
- Chicago, IL21 studier
- Philadelphia, PA21 studier
Andre studier i Myrtle Beach
- Prostatakreft24 studier
- Ikke-muskulinvasiv blærecancer9 studier
- Nyrekreft (nyrecellekarcinom)6 studier
- Urotelial (overgangscelle) karcinom5 studier
- Metastatisk kreft5 studier
- Type 2-diabetes3 studier
- Kastrasjonsresistent prostatakreft3 studier
- Kreft (alle typer)3 studier
- Carcinom in situ3 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.